Unexpectedly, some increase in PD‐L1 expression was detected in the distant tumor, prompting the authors to combine internal radioisotope therapy with immunotherapy to inhibit the remote tumor growth through coadministration of an immune checkpoint inhibitor (αPD‐L1). This evidence concerns the gene CD274 and neoplasm.